Paper
Magrolimab Plus Azacitidine Versus Placebo Plus Azacitidine in Patients With Untreated Higher-Risk Myelodysplastic Syndromes: The Phase III ENHANCE Study
Journal of Clinical Oncology · 2026 · David A Sallman, Guillermo Garcia-Manero, Naval Daver et al.